Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market 2020-2026

Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Size, Share & Trends Analysis Report by Drug Type (Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others) Forecast, 2020-2026

The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is projected to grow at a modest CAGR of 3.5% during the forecast period (2020-2026). The key aspect that drives the growth of the market includes the rising incidences of diabetes particularly type 2 among the people across the globe. The prevalence of diabetes in 2019 across the globe was more than 463 million and is projected to increase over the forecast period as per the International Diabetes Federation (IDF)'s projections. The dipeptidyl peptidase 4 (DPP-4) inhibitors aids in the release of insulin secretion in the patients' body and regulates the sugar levels in the body. Hence, such factors are likely to enhance the growth of the market over the forecast period. However, numerous side effects associated with the intake of dipeptidyl peptidase 4 (DPP-4) inhibitors in form of drugs challenge the growth of the market.

The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is segmented on the basis of drug type. Based on the drug type, the market is segmented as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types of the global dipeptidyl peptidase 4 (DPP-4) inhibitors, the Sitagliptin and Saxagliptin are projected to hold the most lucrative share in the market. Geographically, the global dipeptidyl peptidase 4 (DPP-4) inhibitors market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is anticipated to grow considerably over the forecast period.

Further, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Merck & Co., Eli Lily & Co., GlaxoSmithKline Plc, LG Life Sciences Ltd., Novartis AG, Phenomix Corp., and Takeda Pharmaceutical Co. among others are some of the prominent players functioning in the global dipeptidyl peptidase 4 (DPP-4) inhibitors market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.

Research Methodology

The market study of the global dipeptidyl peptidase 4 (DPP-4) inhibitors market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

Financial reports of companies involved in the market
Whitepapers, research-papers, and news blogs
Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Research and Analysis by Drug Type

The Report Covers

Comprehensive Research Methodology of the global dipeptidyl peptidase 4 (DPP-4) inhibitors market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Dipeptidyl peptidase 4 (DPP-4) inhibitors market.
Insights about market determinants which are stimulating the global dipeptidyl peptidase 4 (DPP-4) inhibitors market.
Detailed and extensive market segments with regional distribution of forecast revenues.
Extensive profiles and recent developments of the market players.

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Industry
Recovery Scenario of Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Industry

1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Merck & Co.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Novartis AG
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Eli Lily &Co.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Boehringer Ingelheim International GmbH
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market by Drug Type
5.1.1. Sitagliptin
5.1.2. Vildagliptin
5.1.3. Saxagliptin
5.1.4. Linagliptin
5.1.5. Gemigliptin
5.1.6. Anagliptin
5.1.7. Teneligliptin
5.1.8. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. ASEAN
6.3.5. South Korea
6.3.6. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. AstraZeneca Plc
7.2. Boehringer Ingelheim International GmbH
7.3. Bristol Myers Squibb Co.
7.4. Eli Lily & Co.
7.5. GlaxoSmithKline Plc
7.6. Kowa Co. Ltd.
7.7. LG Life Sciences Ltd.
7.8. Merck & Co.
7.9. Novartis AG
7.10. Pfizer Inc.
7.11. Phenomix Corp.
7.12. Sanofi SA
7.13. Sanwa Kagaku Kenkyusho Co. Ltd.
7.14. SatRx LLC
7.15. Takeda Pharmaceutical Co.List of Tables
1. Global Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Drug Type, 2019-2026 ($ Million)
2. Global Sitagliptinmarket Research and Analysis by Region, 2019-2026 ($ Million)
3. Global Vildagliptinmarket Research and Analysis by Region, 2019-2026 ($ Million)
4. Global Saxagliptin Market Research and Analysis by Region, 2019-2026 ($ Million)
5. Global Linagliptin Market Research and Analysis by Region, 2019-2026 ($ Million)
6. Global Gemigliptin Market Research and Analysis by Region, 2019-2026 ($ Million)
7. Global Anagliptinmarket Research and Analysis by Region, 2019-2026 ($ Million)
8. Global Teneligliptin Market Research and Analysis by Region, 2019-2026 ($ Million)
9. Global Otherdrug Types Market Research and Analysis by Region, 2019-2026 ($ Million)
10. Global Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Geography, 2019-2026 ($ Million)
11. North American Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Country, 2019-2026 ($ Million)
12. North American Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Drug Type, 2019-2026 ($ Million)
13. European Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Country, 2019-2026 ($ Million)
14. European Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Drug Type, 2019-2026 ($ Million)
15. Asia-Pacific Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Country, 2019-2026 ($ Million)
16. Asia-Pacific Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Drug Type, 2019-2026 ($ Million)
17. Rest of the World Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Research and Analysis by Drug Type, 2019-2026 ($ Million)List of Figures
1. Global Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Share by Drug Type, 2019 Vs 2026 (%)
2. Global Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Share by Geography, 2019 Vs 2026 (%)
3. Us Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
4. Canada Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
5. UK Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
6. France Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
7. Germany Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
8. Italy Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
9. Spain Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
10. Roe Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
11. India Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
12. China Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
13. Japan Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
14. Asean Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
15. South Korea Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
16. Rest of Asia-Pacific Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)
17. Rest of the World Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors Market Size, 2019-2026 ($ Million)